Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ADAP Adaptimmune Therapeutics plc

已收盘 11-22 16:00:00 EST

0.6616

+0.0250

+3.93%

盘后0.6600

-0.0016-0.24%

19:19 EST

最高0.6648	最低0.6000	成交量134.16万
今开0.6300	昨收0.6366	日振幅10.18%
总市值1.69亿	流通市值1.05亿	总股本2.56亿
成交额84.74万	换手率0.85%	流通股本1.59亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"ADAP","market":"US","secType":"STK","nameCN":"Adaptimmune Therapeutics plc","latestPrice":0.6616,"timestamp":1732309200000,"preClose":0.6366,"halted":0,"volume":1341606,"hourTrading":{"tag":"盘后","latestPrice":0.66,"preClose":0.6616,"latestTime":"19:19 EST","volume":1776,"amount":1166.7115,"timestamp":1732321151420},"delay":0,"floatShares":158542457,"shares":255745445,"eps":-0.181467,"marketStatus":"已收盘","marketStatusCode":5,"change":0.025,"latestTime":"11-22 16:00:00 EST","open":0.63,"high":0.6648,"low":0.6,"amount":847380.3519384,"amplitude":0.101791,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.181467,"exchange":"NASDAQ","tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1732525200000},"adr":1,"listingDate":1430884800000,"adjPreClose":0.6366,"adrRate":6,"preHourTrading":{"tag":"盘前","latestPrice":0.6103,"preClose":0.6366,"latestTime":"09:22 EST","volume":7412,"amount":5540.430716399999,"timestamp":1732285374377},"postHourTrading":{"tag":"盘后","latestPrice":0.66,"preClose":0.6616,"latestTime":"19:19 EST","volume":1776,"amount":1166.7115,"timestamp":1732321151420},"volumeRatio":0.385937,"impliedVol":0.4689,"impliedVolPercentile":0.0794},"requestUrl":"/m/hq/s/ADAP","defaultTab":"news","newsList":[{"id":"2485962298","title":"Adaptimmune Therapeutics Plc2024财年第三财季实现净利润-17.80百万美元，同比增加60.74%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485962298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485962298?lang=zh_cn&edition=full","pubTime":"2024-11-23 00:01","pubTimestamp":1732291266,"startTime":"0","endTime":"0","summary":"11月23日，Adaptimmune Therapeutics Plc公布财报，公告显示公司2024财年第三财季净利润为-17.80百万美元，同比增加60.74%；其中营业收入为41.32百万美元，同比增加467.58%，每股基本收益为-0.07美元。从资产负债表来看，Adaptimmune Therapeutics Plc总负债2.37亿美元，其中短期债务4.18百万美元，资产负债比为1.34，流动比率为0.04。机构评级：截至2024年11月23日，当前有9家机构对Adaptimmune Therapeutics Plc目标价做出预测，其中目标均价为2.88美元，其中最低目标价为1.00美元，最高目标价为6.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000135a24e48b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241123000135a24e48b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP"],"gpt_icon":0},{"id":"2485423424","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2485423424","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2485423424?lang=zh_cn&edition=full","pubTime":"2024-11-22 04:54","pubTimestamp":1732222480,"startTime":"0","endTime":"0","summary":"北京时间2024年11月22日04时54分，Adaptimmune Therapeutics Plc股票出现波动，股价大幅下跌5.09%。截至发稿，该股报0.631美元/股，成交量75.1195万股，换手率0.29%，振幅7.46%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.37%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122045440a24c12e6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241122045440a24c12e6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","LENZ","BK4139"],"gpt_icon":0},{"id":"2484248449","title":"Adaptimmune Therapeutics Plc盘中异动 早盘股价大涨5.48%报0.628美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484248449","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484248449?lang=zh_cn&edition=full","pubTime":"2024-11-19 23:52","pubTimestamp":1732031523,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日23时52分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅上涨5.48%。截至发稿，该股报0.628美元/股，成交量388.148万股，换手率1.52%，振幅9.48%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.80%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119235203abcf8e5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241119235203abcf8e5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ADAP"],"gpt_icon":0},{"id":"2484670264","title":"Adaptimmune Therapeutics Plc盘中异动 早盘股价大涨5.11%报0.617美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484670264","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484670264?lang=zh_cn&edition=full","pubTime":"2024-11-19 00:13","pubTimestamp":1731946430,"startTime":"0","endTime":"0","summary":"北京时间2024年11月19日00时13分，Adaptimmune Therapeutics Plc股票出现异动，股价快速上涨5.11%。截至发稿，该股报0.617美元/股，成交量58.0977万股，换手率0.23%，振幅4.62%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.07%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900135098e434d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111900135098e434d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2483050876","title":"美国研究综述-思科、Freshpet、Nvidia","url":"https://stock-news.laohu8.com/highlight/detail?id=2483050876","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483050876?lang=zh_cn&edition=full","pubTime":"2024-11-14 20:06","pubTimestamp":1731585982,"startTime":"0","endTime":"0","summary":"美国研究综述-思科、Freshpet、Nvidia路透11月14日 - 华尔街证券分析师周四调整了对思科、Freshpet 和 Nvidia 等几家美国上市公司的评级和目标价。要闻 * 思科CSCO.O：杰富瑞将目标价从53美元上调至66美元 * Freshpet Inc FRPT.O：奥本海默将目标价从155美元上调至180美元  * ICU Medical Inc ICUI.O：Raymond James将目标价从190美元上调至205美元  * Kronos Bio Inc KRON.O：TD Cowen将目标价从买入下调至持有 * Nvidia Corp NVDA.O：奥本海默将目标价从 150 美元上调至 175 美元 以下是路透周四报导的美国公司研究行动摘要。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241114:nL4T3ML18A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CHX","IE00BFXG1179.USD","BK4209","BTMD","APEI","ALSN","AZTA","SLRN","FDMT","CTRA","CNNE","AIT","LU0234572021.USD","ACRV","BPMC","CAKE","COGT","CBSH","CPB","CPAY","SG9999002232.USD","IE00BZ1G4Q59.USD","ALMS","CRVS","CSCO","AMGN","LU1244550494.USD","BIIB","ADAP","BKR","LU0868494708.USD","BWXT","AXTA","LU1244550577.SGD","CHGG","CAVA","ALLO","AROC","AVB","CPT","APD","LU0300736492.USD","LU1894683348.USD","BK4550","LU2106854487.HKD","SPRY","EE","AESI","DOX","BRBR"],"gpt_icon":0},{"id":"2483833213","title":"BUZZ--美国股票走势-BankUnited, Natera, Adaptimmune","url":"https://stock-news.laohu8.com/highlight/detail?id=2483833213","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483833213?lang=zh_cn&edition=full","pubTime":"2024-11-14 00:01","pubTimestamp":1731513684,"startTime":"0","endTime":"0","summary":"        *      Eikon 个股走势搜索字符串：[STXBZ］        *      The Day Ahead 新闻通讯：          *      The Morning News Call时事通讯：      11月13日 - 周三，华尔街主要股指走高，因消费者价格通胀数据符合预期，使美国联邦储备理事会有望在12月再次降息。美国东部时间10:31，道琼斯工业平均指数  上涨0.10%，报43956.01点；标普500指数  下跌0.08%，报5979.25点；纳斯达克综合指数  下跌0.25%，报19232.38点。** BTC Digital Ltd   ，上涨 63.7  纳斯达克  百分比跌幅前三名：** Syros Pharmaceuticals Inc   ，下跌 86.1% ** GlucoTrack Inc   ，下跌 74.4 ** Wag！","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LXEO","RIVN","SDOW","ETNB","NQmain","SSYS","AMGN","SQQQ","TQQQ",".DJI","COTY",".IXIC","BRTX","GEV","SAIA","KNX","MNQmain","GDYN","CTRA","HTLD","CAT","POAI","HON","PAY","VVX",".SPX","QLD","ALB","ODFL","DOG","CART","DXD","DAVE","DDM","SPOT","CAVA","ADAP","SAVE","SWKS","SYRS","PSQ","BKU","QID","NTRA","DJX"],"gpt_icon":1},{"id":"2483988150","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483988150","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483988150?lang=zh_cn&edition=full","pubTime":"2024-11-13 22:41","pubTimestamp":1731508908,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日22时41分，Adaptimmune Therapeutics Plc股票出现异动，股价快速上涨5.00%。截至发稿，该股报0.833美元/股，成交量5.9732万股，换手率0.02%，振幅1.31%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.30%。其相关个股中，Celularity Inc C/Wts 16/07/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、Lexeo Therapeutics, Inc.涨幅较大，Cyclacel Pharmaceuticals, Inc.、Elevai Labs, Inc.、Tharimmune, Inc.较为活跃，换手率分别为339.53%、197.29%、90.05%，振幅较大的相关个股有Lexeo Therapeutics, Inc.、Immunoprecise Antibodies Ltd.、Atara Biotherapeutics, Inc.，振幅分别为29.52%、26.81%、24.46%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224148971a64b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113224148971a64b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","LENZ","BK4139"],"gpt_icon":0},{"id":"2483765820","title":"美股异动丨ADAP盘前大涨超19% 即将发布Q3财报","url":"https://stock-news.laohu8.com/highlight/detail?id=2483765820","media":"港股那点事","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483765820?lang=zh_cn&edition=full","pubTime":"2024-11-13 17:33","pubTimestamp":1731490380,"startTime":"0","endTime":"0","summary":"格隆汇11月13日｜Adaptimmune Therapeutics(ADAP.US)盘前涨超19%，报0.94美元。消息上，公司将于美东时间11月13日盘后发布财报。机构预期公司2024Q3实现营收2048.89万美元，同比增加179.94%。(格隆汇)\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/bxjj/2024-11-13/doc-incvxhxq2287933.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/bxjj/2024-11-13/doc-incvxhxq2287933.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["ADAP"],"gpt_icon":0},{"id":"2483538070","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483538070","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483538070?lang=zh_cn&edition=full","pubTime":"2024-11-13 03:13","pubTimestamp":1731438809,"startTime":"0","endTime":"0","summary":"北京时间2024年11月13日03时13分，Adaptimmune Therapeutics Plc股票出现异动，股价快速下跌5.01%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.86%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、美第奇新星生物技术、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025涨幅较大，Genprex, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为561.58%、438.07%、254.36%，振幅较大的相关个股有60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Geovax Labs Inc C/Wts 29/09/2025、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ，振幅分别为209.30%、105.45%、86.87%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113031329971a619f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113031329971a619f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2481156054","title":"Adaptimmune Therapeutics Plc盘中异动 临近收盘急速跳水5.27%报0.784美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481156054","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481156054?lang=zh_cn&edition=full","pubTime":"2024-11-08 04:34","pubTimestamp":1731011686,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日04时34分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅下跌5.27%。截至发稿，该股报0.784美元/股，成交量60.4794万股，换手率0.24%，振幅5.58%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为1.28%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108043446971a52e8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108043446971a52e8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","LENZ","BK4139"],"gpt_icon":0},{"id":"2481538200","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨5.03%报0.840美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2481538200","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481538200?lang=zh_cn&edition=full","pubTime":"2024-11-04 23:58","pubTimestamp":1730735906,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日23时58分，Adaptimmune Therapeutics Plc股票出现异动，股价急速拉升5.03%。截至发稿，该股报0.840美元/股，成交量21.8862万股，换手率0.09%，振幅7.38%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.39%。其相关个股中，Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大，Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃，换手率分别为278.93%、265.90%、69.44%，振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Kazia Therapeutics Limited，振幅分别为52.25%、45.39%、39.13%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104235826971a4354&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241104235826971a4354&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2480056770","title":"Adaptimmune Therapeutics Plc盘中异动 股价大涨5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480056770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480056770?lang=zh_cn&edition=full","pubTime":"2024-11-01 00:45","pubTimestamp":1730393117,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日00时45分，Adaptimmune Therapeutics Plc股票出现异动，股价快速拉升5.45%。截至发稿，该股报0.735美元/股，成交量59.4409万股，换手率0.23%，振幅5.01%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为3.36%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101004517971a39bc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101004517971a39bc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2479256664","title":"Adaptimmune Therapeutics Plc盘中异动 临近收盘快速跳水5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479256664","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479256664?lang=zh_cn&edition=full","pubTime":"2024-10-30 03:35","pubTimestamp":1730230539,"startTime":"0","endTime":"0","summary":"北京时间2024年10月30日03时35分，Adaptimmune Therapeutics Plc股票出现波动，股价急速下跌5.05%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.38%。其相关个股中，Glycomimetics, Inc.、Estrella Immunopharma Inc C/Wts 29/09/2028、Lixte Biotechnology Holdings, Inc.涨幅较大，Glycomimetics, Inc.、Lixte Biotechnology Holdings, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为1670.62%、1428.06%、360.72%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Dermata Therapeutics Inc C/Wts ，振幅分别为183.65%、88.24%、78.31%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103003353998e3f2d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103003353998e3f2d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2478654776","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.02%报0.746美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478654776","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478654776?lang=zh_cn&edition=full","pubTime":"2024-10-25 00:20","pubTimestamp":1729786833,"startTime":"0","endTime":"0","summary":"北京时间2024年10月25日00时20分，Adaptimmune Therapeutics Plc股票出现异动，股价快速下挫5.02%。截至发稿，该股报0.746美元/股，成交量59.3985万股，换手率0.23%，振幅3.69%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.12%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025002033971a21d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241025002033971a21d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","BK4139","LENZ"],"gpt_icon":0},{"id":"2474581229","title":"Adaptimmune Therapeutics Plc盘中异动 急速跳水5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2474581229","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474581229?lang=zh_cn&edition=full","pubTime":"2024-10-09 22:06","pubTimestamp":1728482775,"startTime":"0","endTime":"0","summary":"北京时间2024年10月09日22时06分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅下挫5.00%。截至发稿，该股报0.863美元/股，成交量35.3288万股，换手率0.14%，振幅4.04%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.66%。其相关个股中，Psyence Biomedical Ltd C/Wts 25/01/2029、Inhibikase Therapeutics, Inc.、Kezar Life Sciences, Inc.涨幅较大，Windtree Therapeutics, Inc.、Aditxt, Inc.、Inhibikase Therapeutics, Inc.较为活跃，换手率分别为653.68%、294.68%、116.17%，振幅较大的相关个股有Cue Biopharma, Inc.、Inhibikase Therapeutics, Inc.、Sonnet Biotherapeutics Holdings, Inc.，振幅分别为39.02%、35.29%、19.67%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009220615a1df6cb3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241009220615a1df6cb3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ADAP","BK4139"],"gpt_icon":0},{"id":"2473485081","title":"Adaptimmune Therapeutics Plc盘中异动 股价大跌5.24%报0.901美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473485081","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473485081?lang=zh_cn&edition=full","pubTime":"2024-10-08 00:36","pubTimestamp":1728318988,"startTime":"0","endTime":"0","summary":"北京时间2024年10月08日00时36分，Adaptimmune Therapeutics Plc股票出现波动，股价快速下挫5.24%。截至发稿，该股报0.901美元/股，成交量30.0912万股，换手率0.12%，振幅5.85%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.11%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008003629ab681fce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008003629ab681fce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2472223966","title":"Adaptimmune Therapeutics Plc盘中异动 早盘大幅上涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472223966","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472223966?lang=zh_cn&edition=full","pubTime":"2024-10-04 23:00","pubTimestamp":1728054000,"startTime":"0","endTime":"0","summary":"北京时间2024年10月04日23时00分，Adaptimmune Therapeutics Plc股票出现异动，股价快速拉升5.01%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Tc Biopharm  Plc C/Wts 10/02/2028 、Geovax Labs Inc C/Wts 29/09/2025、Capricor Therapeutics, Inc.涨幅较大，Aditxt, Inc.、Theriva Biologics, Inc.、Windtree Therapeutics, Inc.较为活跃，换手率分别为15096.48%、53.60%、47.76%，振幅较大的相关个股有Geovax Labs Inc C/Wts 29/09/2025、Aditxt, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ，振幅分别为58.64%、47.42%、38.39%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004230000a1de4f12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241004230000a1de4f12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ADAP","LENZ","BK4139"],"gpt_icon":0},{"id":"2472571171","title":"Adaptimmune Therapeutics Plc盘中异动 急速下跌5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2472571171","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472571171?lang=zh_cn&edition=full","pubTime":"2024-10-03 00:59","pubTimestamp":1727888351,"startTime":"0","endTime":"0","summary":"北京时间2024年10月03日00时59分，Adaptimmune Therapeutics Plc股票出现波动，股价急速下挫5.36%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.97%。其相关个股中，Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tc Biopharm  Plc C/Wts 10/02/2028 、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Aditxt, Inc.、Windtree Therapeutics, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为1108.86%、55.63%、51.27%，振幅较大的相关个股有Pasithea Therapeutics Corp C/Wts 12/08/2026 、Apollomics Inc C/Wts 01/04/2028 、Aditxt, Inc.，振幅分别为145.55%、60.44%、51.53%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003005911ab677aaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241003005911ab677aaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ADAP"],"gpt_icon":0},{"id":"2472866331","title":"Adaptimmune Therapeutics Plc盘中异动 下午盘快速下跌5.05%报0.928美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2472866331","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2472866331?lang=zh_cn&edition=full","pubTime":"2024-10-01 01:14","pubTimestamp":1727716497,"startTime":"0","endTime":"0","summary":"北京时间2024年10月01日01时14分，Adaptimmune Therapeutics Plc股票出现异动，股价快速跳水5.05%。截至发稿，该股报0.928美元/股，成交量27.6385万股，换手率0.11%，振幅7.16%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体涨幅为0.06%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010114579719da41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410010114579719da41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","ADAP"],"gpt_icon":0},{"id":"2470408179","title":"Adaptimmune Therapeutics Plc盘中异动 急速上涨5.46%报0.988美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2470408179","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2470408179?lang=zh_cn&edition=full","pubTime":"2024-09-27 22:06","pubTimestamp":1727446018,"startTime":"0","endTime":"0","summary":"北京时间2024年09月27日22时06分，Adaptimmune Therapeutics Plc股票出现异动，股价大幅拉升5.46%。截至发稿，该股报0.988美元/股，成交量19.0418万股，换手率0.07%，振幅5.59%。Adaptimmune Therapeutics Plc股票所在的生物技术行业中，整体跌幅为0.65%。Adaptimmune Therapeutics Plc公司简介：Adaptimmune Therapeutics PLC 是一家临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927220659a1dd12b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240927220659a1dd12b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ADAP","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.adaptimmune.com","stockEarnings":[{"period":"1week","weight":0.0768},{"period":"1month","weight":-0.2141},{"period":"3month","weight":-0.4739},{"period":"6month","weight":-0.3937},{"period":"1year","weight":0.4178},{"period":"ytd","weight":-0.1972}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Adaptimmune Therapeutics Plc成立于2014年12月3日，是一家根据英格兰和威尔士法律注册成立的公众有限公司。该公司是一家临床阶段的生物制药公司，将于2024年过渡到商业阶段的细胞治疗公司。该公司专注于为癌症患者提供新型细胞疗法。公司第一个产品，afamitresgene autoleucel或“afami-cel”是滑膜肉瘤特有的，将是肉瘤产品专营的第一个产品。他们计划于2026年在美国商业推出的Lete-cel将是肉瘤专营权的第二个产品，将同时针对滑膜肉瘤和粘液样圆细胞脂肪肉瘤，显著扩大可治疗的患者群体。","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.258042},{"month":2,"riseRate":0.333333,"avgChangeRate":0.016975},{"month":3,"riseRate":0.444444,"avgChangeRate":0.008185},{"month":4,"riseRate":0.666667,"avgChangeRate":0.067805},{"month":5,"riseRate":0.333333,"avgChangeRate":0.165831},{"month":6,"riseRate":0.3,"avgChangeRate":-0.040994},{"month":7,"riseRate":0.4,"avgChangeRate":-0.012797},{"month":8,"riseRate":0.4,"avgChangeRate":-0.021406},{"month":9,"riseRate":0.4,"avgChangeRate":-0.036238},{"month":10,"riseRate":0.1,"avgChangeRate":-0.217057},{"month":11,"riseRate":0.4,"avgChangeRate":0.044432},{"month":12,"riseRate":0.444444,"avgChangeRate":0.034379}],"exchange":"NASDAQ","name":"Adaptimmune Therapeutics plc","nameEN":"Adaptimmune Therapeutics PLC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Adaptimmune Therapeutics plc,ADAP,Adaptimmune Therapeutics plc股票,Adaptimmune Therapeutics plc股票老虎,Adaptimmune Therapeutics plc股票老虎国际,Adaptimmune Therapeutics plc行情,Adaptimmune Therapeutics plc股票行情,Adaptimmune Therapeutics plc股价,Adaptimmune Therapeutics plc股市,Adaptimmune Therapeutics plc股票价格,Adaptimmune Therapeutics plc股票交易,Adaptimmune Therapeutics plc股票购买,Adaptimmune Therapeutics plc股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Adaptimmune Therapeutics plc(ADAP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Adaptimmune Therapeutics plc(ADAP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}